Početna › Dijabetes tipa 1 › Pennsylvania
Kliničke studije za Dijabetes tipa 1 u državi Pennsylvania
13 studija za Dijabetes tipa 1 traži sudionike na lokacijama u državi Pennsylvania.
Gradovi u državi Pennsylvania
Službeni tekst studije (engleski)
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
- Children's Hospital of Philadelphia (CHOP), Philadelphia
U tijeku regrutacijaFaza 3
Od 1 do 35 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07222137A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
- Children's Hospital of Philadelphia (CHOP), Philadelphia
U tijeku regrutacijaFaza 3
Od 1 do 35 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07222332A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- The Children's Hospital of Philadelphia- Site Number : 8400039, Philadelphia
U tijeku regrutacijaFaza 3
Od 1 do 25 godina · Oba spola · Ažurirano 14. ruj 2026. · NCT07088068Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
- University of Pittsburgh, Pittsburgh
U tijeku regrutacijaFaza 2
Od 4 do 34 godina · Oba spola · Ažurirano 9. ruj 2026. · NCT07216391Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
- University of Pittsburgh, Pittsburgh
U tijeku regrutacijaFaza 2
Od 8 do 45 godina · Oba spola · Ažurirano 8. ruj 2026. · NCT07142252A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
- University of Pittsburgh, Pittsburgh
U tijeku regrutacijaFaza 1/2
Od 9 do 20 godina · Oba spola · Ažurirano 2. ruj 2026. · NCT07061574A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
- Hospital of the University of Pennsylvania, Philadelphia
- University of Pittsburgh Medical Center Montefiore, Pittsburgh
U tijeku regrutacijaFaza 3
Od 18 do 65 godina · Oba spola · Ažurirano 1. ruj 2026. · NCT04786262SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
- The Children's Hospital of Philadelphia, Philadelphia
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
U tijeku regrutacijaFaza 2
Od 5 do 40 godina · Oba spola · Ažurirano 24. kol 2026. · NCT07187531Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery
- University of Pennsylvania, Philadelphia
U tijeku regrutacija
Od 18 do 65 godina · Oba spola · Ažurirano 16. srp 2026. · NCT06880835Registry for Stage 2 Type 1 Diabetes
- Hospital of The University of Pennsylvania- Site Number : 8400021, Philadelphia
- The Children's Hospital of Philadelphia- Site Number : 8400029, Philadelphia
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 13. tra 2026. · NCT06481904An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant
- Perelman Center for Advanced Medicine - Endocrinology, Philadelphia
- Montefiore Clinical and Translational Research Center - Endocrinology, Pittsburgh
U tijeku regrutacijaFaza 3
Od 18 do 65 godina · Oba spola · Ažurirano 23. ožu 2026. · NCT06832410Closed Loop and Education for Hypoglycemia Awareness Restoration
- University of Pennsylvania, Philadelphia
U tijeku regrutacija
Od 18 do 75 godina · Oba spola · Ažurirano 3. ožu 2026. · NCT06325202TrialNet Pathway to Prevention of T1D
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 2 do 45 godina · Oba spola · Ažurirano 1. srp 2025. · NCT00097292Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.